CLOV vs IMNM · rev $1.37B vs rev $9.0M
Clover Health Investments Corp (CLOV) versus Immunome Inc (IMNM) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Immunome Inc (IMNM) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IMNM revenue for 2024-12-31 was $9.0M. Net income was -$293.0M. Revenue was down 35.5% from 2023-12-31 to 2024-12-31. IMNM currently screens at market cap $2.47B.
CLOV currently screens at market cap $1.55B. IMNM currently screens at market cap $2.47B.
Not investment advice. Open the CLOV and IMNM stock pages for the full models.
Not investment advice.